Stay updated with breaking news from Clinical Trials Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
The Lupus Research Alliance and its affiliate Lupus Therapeutics presented data at ACR Convergence 2022 with results showing the effectiveness of a pilot peer education program called the Patient Advocates for Lupus Studies (PALS), in increasing knowledge, perception, and willingness among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials.
/PRNewswire/ -- The Lupus Research Alliance and its affiliate Lupus Therapeutics will present data at ACR Convergence 2022 with results showing the...
The three-month virtual UH certificate program will prepare individuals for a thriving career in clinical research to better serve Hawaiʻi’s cancer patients.